[Therapy of orthostatic regulation disorders. Comparative study with Novadral retard R, Acetyl-Novadral, Wv 1501 and placebo in ambulatory patients].
D000085:Acetates / Q000627:therapeutic use; D000284:Administration, Oral; D000605:Amino Alcohols / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics; D006801:Humans; D007024:Hypotension, Orthostatic / Q000188:drug therapy*; D008297:Male; D009655:Octopamine / Q000627:therapeutic use; D010080:Oxazoles / Q000627:therapeutic use*; D010113:Oxyphenbutazone / Q000494:pharmacology; D010627:Phenethylamines / Q000627:therapeutic use*; D010919:Placebos; D011187:Posture; D011725:Pyridines / Q000627:therapeutic use; D012119:Respiration / Q000187:drug effects
D000085:Acetates; D000605:Amino Alcohols; D010080:Oxazoles; D010627:Phenethylamines; D010919:Placebos; D011725:Pyridines; D009655:Octopamine; D010113:Oxyphenbutazone
Zur Therapie orthostatischer Regulationsstörungen. Vergleichende Behandlung ambulanter Paitenten mit Novadral retard, Acetyl-Novadral, WV 1501 und Placebo.